Top journals
Frequent coauthors
- Weill A 8
- Noémie Roland 7
- Froelich S 5
- Lise Duranteau 5
- Hoisnard L 4
- Joël Coste 3
- Dray-Spira R 3
- Baricault B 3
- Neumann A 3
- Passeri T 3
2025
BackgroundA decrease in oral contraceptive use, newly available methods, and the emerging role of midwives suggested meaningful changes in contraception use in France. With two repeated cross-sectional studies, we aimed to describe contrace…
2025
ObjectiveTo assess the risk of intracranial meningioma associated with oral contraceptives containing desogestrel, levonorgestrel, or levonorgestrel combined with oestrogen.DesignCase-control study.SettingFrench national health data system …
2025
Background and purposeChlormadinone acetate (CMA) is a synthetic progestin for which cases of intracranial meningioma have been reported following prolonged exposure.MethodAn observational cohort study was conducted based on the French nati…
2024
BackgroundNomegestrol acetate (NOMAC) is a synthetic potent progestogen. This study aimed to assess the risk of intracranial meningioma associated with the prolonged use of NOMAC.MethodsObservational cohort study using SNDS data (France). W…
2024
ObjectiveTo assess the risk of intracranial meningioma associated with the use of selected progestogens.DesignNational case-control study.SettingFrench National Health Data System (ie, Système National des Données de Santé).ParticipantsOf 1…
2023
2023
ObjectiveTo assess the user profiles of copper intrauterine devices (Cu-IUD) and levonorgestrel intrauterine systems (LNG-IUS) in France in 2019 and the rates of continuation 1 year later.MethodsA population-based study was conducted of all…
2022
Background and purposeA dose-dependent association between the use of cyproterone acetate (CPA) and intracranial meningioma has been identified but data for other potent progestogens are scarce. The association was assessed between intracra…